Treatment of cytomegalovirus retinitis with intraocular implants. (includes test for continuing education credit) From: AORN Journal | Date: February 1, 1998| Author: Constabile, Bruce S. | COPYRIGHT 1998 Association of Operating Room Nurses, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Cytomegalovirus (CMV) retinitis affects 20% to 40% of patients with AIDS end is the leading cause of vision loss associated with AIDS. Three treatment options currently exist (ie, IV administration of antiviral medications, intravitreal injections of ganciclovir, surgical implantation of devices that provide sustained release of ganciclovir). As patients with AIDS live longer, perioperative nurses may care for more patients with CMV retinitis who undergo implantation of these devices. AORN J ...

Related newspaper, magazine, and journal articles from HighBeam Research

	Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus and end-stage renal disease Mayo Clinic Proceedings ; Rheumatic diseases are not commonly associated with cytomegalovirus (CMV) retinitis. We report a case of bilateral CMV retinitis in a human immunodeficiency virusseronegative patient with systemic lupus erythematosus (SLE) who was undergoing hemodialysis for end-stage renal disease. The CMV
	Race and The Treatment of Cytomegalovirus Retinitis in A Cohort of Patients With Acquired Immunodeficiency Syndrome Journal of the National Medical Association ; This historical cohort study assessed the impact of race on critical factors in the diagnosis and drug treatment of cytomegalovirus (CMV) retinitis in acquired immunodeficiency syndrome (AIDS) patients over a 7-year period. The study subjects included 194 adult patients with a history of AIDS who
	Treatment of cytomegalovirus retinitis with intraocular implants. (includes test for continuing education credit) AORN Journal ; The article Treatment of cytomegalovirus retinitis with intraocular implants is the basis for this AORN Journal independent study. The behavioral objectives and examination for this program were prepared by Helen Starbuck Pashley, RN, MA, CNOR, with consultation from Trish O'Neill, RN, MS,
	HAART link study sought Ophthalmology Times ; WASHINGTON, DC-Roche's valganciclovir phase IV studies should address the effect of highly active antiretroviral therapy on the drug's efficacy for maintenance therapy in cytomegalovirus retinitis, FDA's Antiviral Drugs Advisory Committee said. Committee members questioned whether valganciclovir's
	Yellow-white retinal lesion in a 48-year-old woman.(Photo Quiz) American Family Physician ; A 48-year-old woman presented with a two-week history of progressively decreasing vision in her right eye. Her medical history included systemic lupus erythematosus, severe arthritis, hypertension, and diabetes mellitus. She had been taking oral prednisone, azathioprine (Imuran), amlodipine
	CMV retinitis presents a changing clinical picture Ophthalmology Times ; COLE EYE INSTITUTE SYMPOSIUM AIDS epidemic has increased frequency; newer drugs have altered treatment approach CLEVELAND-Cytomegalovirus (CMV) retinitis is a disease in transition, and a new chapter in its history is beginning, Gary N. Holland, MD, said in a presentation at the dedication of the
	New CMV treatments finally arriving for HIV patients Drug Topics ; Treatment for cytomegalovirus (CMV) infection in HIV patients is finally getting easier. In October, the Food & Drug Administration expanded the indication for oral ganciclovir (Cytovene, Roche Bioscience) to include prevention of CMV, including CMV retinitis, in advanced AIDS patients. The
	Experimental drug allowed for AIDS-related eye infections.(cidofir authorized to treat relapsing cytomegalovirus retinitis)(Brief Article) FDA Consumer ; Under a treatment IND recently authorized by FDA, doctors may use the investigational drug intravenous Vistide (cidofovir) to treat HIV-infected patients with relapsing cytomegalovirus (CMV) retinitis that has progressed despite treatment. CMV retinitis is an eye infection that can lead to
	Valcyte Formulary ; Valganciclovir HCI tablets ROCHE Oral antiviral for Induction and maintenance Tx of CMV retinitis Valganciclovir has been approved for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS. The agent is the prodrug of ganciclovir, which is approved in injectable form for the same
	CMV retinitis treatment responding to changing HIV therapy Ophthalmology Times ; Discussion Uveitis Update Roundtable participants: James P. Dunn Jr., MD Associate professor of ophthalmology, The Wilmer Ophthalmological Institute, Division of Ocular Immunology, Baltimore William R. Freeman, MD Professor of ophthalmology, department of ophthalmology, UCSD School of Medicine,

See all results.